Cargando…

What strategies do ulcerative colitis patients employ to facilitate adherence?

BACKGROUND: Overall, 30%–45% of patients with ulcerative colitis (UC) are non-adherent and have difficulties taking their medications; this non-adherence increases the risk of clinical relapse 1.4- to 5.5-fold. This study aimed to clarify the strategies patients employ to facilitate adherence and de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawakami, Aki, Tanaka, Makoto, Naganuma, Makoto, Maeda, Shin, Kunisaki, Reiko, Yamamoto-Mitani, Noriko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293502/ https://www.ncbi.nlm.nih.gov/pubmed/28203059 http://dx.doi.org/10.2147/PPA.S117841

Ejemplares similares

A screening instrument to identify ulcerative colitis patients with the high possibility of current non-adherence to aminosalicylate medication based on the Health Belief Model: a cross-sectional study
por: Kawakami, Aki, et al.
Publicado: (2014)

Self-Reported Medication Adherence Among Patients with Ulcerative Colitis in Japan and the United Kingdom: A Secondary Analysis for Cross-Cultural Comparison
por: Kawakami, Aki, et al.
Publicado: (2022)

Daily life difficulties among patients with ulcerative colitis in Japan and the United Kingdom: A comparative study
por: Kawakami, Aki, et al.
Publicado: (2022)

Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis
por: Naganuma, Makoto
Publicado: (2020)

Current new challenges in the management of ulcerative colitis
por: Fukuda, Tomohiro, et al.
Publicado: (2019)

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Adherence in ulcerative colitis: an overview
por: Testa, Anna, et al.
Publicado: (2017)

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
por: Tajiri, Hitoshi, et al.
Publicado: (2019)

Serrated polyps in patients with ulcerative colitis: Unique clinicopathological and biological characteristics
por: Nishio, Masafumi, et al.
Publicado: (2023)

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice
por: Masuda, Masataka, et al.
Publicado: (2022)

Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels
por: Naganuma, Makoto, et al.
Publicado: (2017)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan
por: Yanagi, Tadahiro, et al.
Publicado: (2019)

Impact of the body mass index on the retention of the anorectal mucosa after double-stapled ileal pouch-anal anastomosis for ulcerative colitis
por: Kimura, Hideaki, et al.
Publicado: (2023)

Inflammatory bowel disease-specific findings are common morphological changes in the ileal pouch with ulcerative colitis
por: Toritani, Kenichiro, et al.
Publicado: (2022)

Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
por: Naganuma, Makoto, et al.
Publicado: (2016)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Patient self-reported symptoms using visual analog scales are useful to estimate endoscopic activity in ulcerative colitis
por: Tsuda, Saya, et al.
Publicado: (2018)

Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
por: Tripathi, Kartikeya, et al.
Publicado: (2021)

Correction to: Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Predictive factors for achievement of mucosal healing by budesonide 2-mg foam in ulcerative colitis: a pooled analysis of data from two clinical trials
por: Hibi, Toshifumi, et al.
Publicado: (2020)

The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry
por: Fukuda, Tomohiro, et al.
Publicado: (2017)

The oral bacterial microbiota facilitates the stratification for ulcerative colitis patients with oral ulcers
por: Xu, Jun, et al.
Publicado: (2023)

Demarcated redness associated with increased vascular density/size: a useful marker of flat-type dysplasia in patients with ulcerative colitis
por: Ikebata, Akiyoshi, et al.
Publicado: (2021)

Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission
por: Hisamatsu, Tadakazu, et al.
Publicado: (2015)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020)

Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy
por: Hata, Keisuke, et al.
Publicado: (2020)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Risk factors for postoperative stoma outlet obstruction in ulcerative colitis
por: Kitahara, Tomoaki, et al.
Publicado: (2020)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
por: Mizuno, Shinta, et al.
Publicado: (2020)

A15 GENETIC OR DIET-ASSOCIATED DEFECTS IN MUCUS FACILITATE ULCERATIVE COLITIS PATHOBIONT-DRIVEN COLITIS
por: Yang, H, et al.
Publicado: (2023)

Retrospective investigation of mesalamine intolerance in patients with ulcerative colitis
por: Minagawa, Yuki, et al.
Publicado: (2022)

Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients
por: Mizuno, Shinta, et al.
Publicado: (2017)

A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study
por: Saito, Daisuke, et al.
Publicado: (2023)

Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
por: Naganuma, Makoto, et al.
Publicado: (2017)

Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis
por: Uchiyama, Kazuhiko, et al.
Publicado: (2021)

Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam
por: Naganuma, Makoto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_llidj34pel0o6unb2cjkudmc0u